Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in Botswana.
The Pharmacogenomics Journal
Vujkovic, Marijana M; Bellamy, Scarlett L SL; Zuppa, Athena F AF; Gastonguay, Marc R MR; Moorthy, Ganesh S GS; Ratshaa, Bakgaki B; Han, Xiaoyan X; Steenhoff, Andrew P AP; Mosepele, Mosepele M; Strom, Brian L BL; Bisson, Gregory P GP; Aplenc, Richard R; Gross, Robert R
Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.
British Journal Of Clinical Pharmacology
Sinxadi, Phumla Z PZ; Leger, Paul D PD; McIlleron, Helen M HM; Smith, Peter J PJ; Dave, Joel A JA; Levitt, Naomi S NS; Maartens, Gary G; Haas, David W DW
Genetic variation in the CYP2B6 gene is related to circulating 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) concentrations: an observational population-based study.
Environmental Health : A Global Access Science Source
Penell, Johanna J; Lind, Lars L; Fall, Tove T; Syvänen, Anne-Christine AC; Axelsson, Tomas T; Lundmark, Per P; Morris, Andrew P AP; Lindgren, Cecilia C; Mahajan, Anubha A; Salihovic, Samira S; van Bavel, Bert B; Ingelsson, Erik E; Lind, P Monica PM
CYP2B6 non-coding variation associated with smoking cessation is also associated with differences in allelic expression, splicing, and nicotine metabolism independent of common amino-acid changes.
Plos One
Bloom, A Joseph AJ; Martinez, Maribel M; Chen, Li-Shiun LS; Bierut, Laura J LJ; Murphy, Sharon E SE; Goate, Alison A
Multiple genetic variants predict steady-state nevirapine clearance in HIV-infected Cambodians.
Pharmacogenetics And Genomics
Bertrand, Julie J; Chou, Monidarin M; Richardson, Danielle M DM; Verstuyft, Céline C; Leger, Paul D PD; Mentré, France F; Taburet, Anne-Marie AM; Haas, David W DW; ,